Omeros Corporation (OMER)
NASDAQ: OMER · Real-Time Price · USD
4.290
+0.030 (0.70%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Omeros Employees
Omeros had 198 employees as of December 31, 2023. The number of employees increased by 2 or 1.02% compared to the previous year.
Employees
198
Change (1Y)
2
Growth (1Y)
1.02%
Revenue / Employee
n/a
Profits / Employee
-$707,288
Market Cap
248.59M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
High Tide | 1,550 |
SOPHiA GENETICS | 430 |
Amarin Corporation | 275 |
Lyell Immunopharma | 224 |
Biodesix | 217 |
Precigen | 202 |
Nektar Therapeutics | 137 |
aTyr Pharma | 59 |
OMER News
- 5 days ago - FDA Grants Rare Pediatric Disease Designation to Omeros' MASP-3 Inhibitor Zaltenibart for Treatment of C3 Glomerulopathy - Business Wire
- 2 months ago - Omeros Corporation (OMER) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Omeros Corporation Reports Second Quarter 2024 Financial Results - Business Wire
- 3 months ago - Omeros Corporation to Announce Second Quarter Financial Results on August 7, 2024 - Business Wire
- 5 months ago - Omeros Announces Webcast Details for Annual Meeting of Shareholders - Business Wire
- 5 months ago - Omeros Corporation Further Strengthens its Balance Sheet through Series of Financing Transactions Extending Maturity on a Majority of its Outstanding Debt into 2028 - Business Wire
- 5 months ago - Omeros Corporation (OMER) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Omeros Corporation Reports First Quarter 2024 Financial Results - Business Wire